Loring Wolcott & Coolidge Fiduciary Advisors LLP Verastem, Inc. Transaction History

Loring Wolcott & Coolidge Fiduciary Advisors LLP

$11.1 Billion
Q3 2024

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.33 - $10.44 $5,940 - $187,920	18,000 Added 103.51%	35,390 $21,000
Q4 2019 Jan 22, 2020	BUY	$0.86 - $1.44 $1,543 - $2,584	1,795 Added 11.51%	17,390 $23,000
Q2 2019 Aug 09, 2019	BUY	$1.25 - $3.14 $15,743 - $39,548	12,595 Added 419.83%	15,595 $24,000
Q1 2019 Apr 08, 2019	SELL	$2.79 - $4.09 $8,091 - $11,861	-2,900 Reduced 49.15%	3,000 $9,000
Q4 2018 Feb 13, 2019	BUY	$3.23 - $7.01 $19,057 - $41,359	5,900 New	5,900 $20,000

Others Institutions Holding VSTM

# of Institutions

Shares Held

297K

Call Options Held

Put Options Held

Telemetry Investments, L.L.C. New York, NY

225K
Shares

$897,750
0.14% of portfolio
Beaumont Financial Partners, LLC

48K
Shares

$191,520
0.0% of portfolio
Eaton Vance Management Boston, MA

20K
Shares

$79,800
0.0% of portfolio
American Portfolios Advisors Holbrook, NY

2.99K
Shares

$11,910
0.0% of portfolio
Brewin Dolphin Wealth Management LTD Conskleagh, Dublin, L2

1.07K
Shares

$4,285
0.0% of portfolio

View Full List

About Verastem, Inc.

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $838M
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

More about VSTM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Loring Wolcott & Coolidge Fiduciary Advisors LLP, based on Form 13F filings with the SEC.

News

Stay updated on Loring Wolcott & Coolidge Fiduciary Advisors LLP with notifications on news.

Account